Paper ยท 39478232
Progressive plasticity during colorectal cancer metastasis.
Moorman A and 38 others. Nature, 2025. Cited by 159 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Progressive plasticity during colorectal cancer metastasis. Papers, record 39478232. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39478232
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Colorectal Neoplasms | Major topic |
| Neoplasm Metastasis | Major topic |
| Cell Plasticity | Major topic |
| Disease Progression | Major topic |
| Humans | |
| Organoids | |
| Cell Differentiation | |
| Cell Lineage | |
| Homeodomain Proteins | |
| Tumor Suppressor Proteins | |
| Female | |
| Male | |
| Neoplastic Stem Cells | |
| Intestines | |
| Tumor Microenvironment |
Source PubMed
Grants9
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| U54 CA274492 | NCI NIH HHS | United States | U54CA274492 | PubMed and NIH | NIH RePORTER |
| T32 GM152349 | NIGMS NIH HHS | United States | T32GM152349 | PubMed | NIH RePORTER |
| P30 CA008748 | NCI NIH HHS | United States | P30CA008748 | PubMed and NIH | NIH RePORTER |
| K08 CA230213 | NCI NIH HHS | United States | K08CA230213 | PubMed and NIH | NIH RePORTER |
| U2C CA233284 | NCI NIH HHS | United States | U2CCA233284 | PubMed and NIH | NIH RePORTER |
| U54 CA209975 | NCI NIH HHS | United States | U54CA209975 | PubMed and NIH | NIH RePORTER |
| R37 CA266185 | NCI NIH HHS | United States | R37CA266185 | PubMed and NIH | NIH RePORTER |
| R01EB027498 | NIH | NIH RePORTER | |||
| T32GM007739 | NIH | NIH RePORTER |
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections3
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Erratum in | 39,789,339 | Author Correction: Progressive plasticity during colorectal cancer metastasis. | https://conductscience.org/library/papers/39789339 | PubMed |
| Erratum in | 42,557,335 | Publisher Correction: Progressive plasticity during colorectal cancer metastasis. | https://conductscience.org/library/papers/42557335 | PubMed |
| Update of | 37,662,289 | PubMed |
References77
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37,059,065 | Metastasis. | Cell | 2023 | https://conductscience.org/library/papers/37059065 | PubMed |
| 2 | 35,022,204 | Hallmarks of Cancer: New Dimensions. | Cancer Discov | 2022 | https://conductscience.org/library/papers/35022204 | PubMed |
| 3 | 29,316,426 | Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer. | Cancer Cell | 2018 | https://conductscience.org/library/papers/29316426 | PubMed |
| 4 | 35,120,664 | Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients. | Cell | 2022 | https://conductscience.org/library/papers/35120664 | PubMed |
| 5 | 37,165,194 | Pan-cancer whole-genome comparison of primary and metastatic solid tumours. | Nature | 2023 | https://conductscience.org/library/papers/37165194 | PubMed |
| 6 | 19,092,804 | Crypt stem cells as the cells-of-origin of intestinal cancer. | Nature | 2009 | https://conductscience.org/library/papers/19092804 | PubMed |
| 7 | 24,282,287 | LGR5 positivity defines stem-like cells in colorectal cancer. | Carcinogenesis | 2014 | https://conductscience.org/library/papers/24282287 | PubMed |
| 8 | 32,169,167 | Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer. | Cell Stem Cell | 2020 | https://conductscience.org/library/papers/32169167 | PubMed |
| 9 | 36,352,230 | Metastatic recurrence in colorectal cancer arises from residual EMP1+ cells. | Nature | 2022 | https://conductscience.org/library/papers/36352230 | PubMed |
| 10 | 32,656,539 | L1CAM defines the regenerative origin of metastasis-initiating cells in colorectal cancer. | Nat Cancer | 2020 | https://conductscience.org/library/papers/32656539 | PubMed |
1 to 10 of 77
See all 77 referencesCited by134
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 159 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,985,075 | Reprogramming cancer at the tipping point. | J Natl Cancer Cent | 2026 | https://conductscience.org/library/papers/42985075 | PubMed |
| 42,982,889 | Longitudinal single-cell profiling of breast tumors highlights immune and epigenetic mechanisms associated with sensitivity to aromatase inhibitors. | Nat Genet | 2026 | https://conductscience.org/library/papers/42982889 | PubMed |
| 42,972,081 | A selective TNKS2 inhibitor for tumor-restricted WNT suppression. | Nat Chem Biol | 2026 | https://conductscience.org/library/papers/42972081 | PubMed |
| 42,972,057 | The genomic and epigenomic evolution of colorectal cancer. | Nat Rev Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42972057 | PubMed |
| 42,926,559 | Niche-dependent epistasis within the cancer genome shapes metastatic fitness. | bioRxiv | 2026 | https://conductscience.org/library/papers/42926559 | PubMed |
| 42,925,343 | Histopathological growth patterns represent a dynamic biological and clinically-relevant terminus of the metastatic cascade. | Cancer Metastasis Rev | 2026 | https://conductscience.org/library/papers/42925343 | PubMed |
| 42,902,326 | Cancer metastasis: biological mechanisms, therapeutic bottlenecks, and emerging interventions. | J Hematol Oncol | 2026 | https://conductscience.org/library/papers/42902326 | PubMed |
| 42,897,542 | Patient-derived organoids for precision oncology in colorectal cancer: from tumor modeling to clinical translation. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42897542 | PubMed |
| 42,875,898 | Rational structure-guided identification of a Bcl-2-targeting peptide with antiproliferative effects on colorectal cancer cells. | J Enzyme Inhib Med Chem | 2026 | https://conductscience.org/library/papers/42875898 | PubMed |
| 42,875,653 | Reframing cancer therapy through tumor plasticity. | Nat Cancer | 2026 | https://conductscience.org/library/papers/42875653 | PubMed |
1 to 10 of 134
See all 134 cited byGenes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| LGR5 | 8,549 | PubTator's text mining | https://conductscience.org/library/genes/8549 | NCBI Gene |
| PROX1 | 5,629 | PubTator's text mining | https://conductscience.org/library/genes/5629 | NCBI Gene |
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39478232
GET https://conductscience.org/api/papers/v1/39478232/authors?page=2